Eric Orwoll, MD
Endocrinology, Diabetes & Metabolism · Portland, ORNPI 1083629570
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $60,320 of the $94,213 with a category attached, or 64.0%. 7 manufacturers reported payments, led by Ultragenyx Pharmaceutical Inc. at 43.7% of the total. Among endocrinology, diabetes & metabolism clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $2355.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ultragenyx Pharmaceutical Inc.$41K
- Amgen$21K
- Radius Health, Inc.$15K
- Astrazeneca AB$8K
- Sanofi US Services Inc.$4K
- Bayer$3K
- plus $1K from 1 others
Across 8 payments — averaging $2022.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$13K
- Radius Health, Inc.$2K
- Biocon Biologics Inc$1K
What the payments were for
- Consulting fees$60,32064%
- Speaking & faculty fees$22,08723%
- Travel & lodging$7,4868%
- Food & beverage$2450%
- Education$4,0754%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 7 | $41,190 |
| Amgen | 4 | $21,091 |
| Radius Health, Inc. | 22 | $14,554 |
| Astrazeneca AB | 2 | $8,370 |
| Sanofi US Services Inc. | 1 | $4,368 |
| Bayer | 3 | $3,264 |
| Agios Pharmaceuticals, Inc. | 1 | $1,375 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$21,000
- TEZSPIRE$6,510
- Tymlos$4,610
- Non-Covered$3,264
- PYRUKYND$1,375
How this compares
$94,213 in reported general payments places this provider in the 90th percentile of 76 endocrinology, diabetes & metabolism providers in Oregon.
See all endocrinology, diabetes & metabolism providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Portland
- Michael McClungPortland$1.3M
- Maria FleseriuPortland$464K
- James NeifingPortland$311K
- Rodica BusuiPortland$255K
- Jonathan PurnellPortland$212K
- Paul DuellPortland$91K
- Sergio FazioPortland$88K
- Nancy CuroshPortland$59K
- Andrew AhmannPortland$56K
- Matthew RiddlePortland$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.